[CASM] CAS Medical Systems, Inc.


Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 1.56 Change: 0.02 (1.3%)
Ext. hours: Change: 0 (0%)

chart CASM

Refresh chart

Strongest Trends Summary For CASM

CASM is in the long-term up 74% above S&P in 2 years and down -70% below S&P in 19 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets medical devices for non-invasive patient monitoring in the United States and internationally. The company provides FORE-SIGHT and FORE-SIGHT ELITE absolute tissue oximeter, a cerebral oximeter that offers noninvasive quantitative measurement of cerebral tissue oxygen levels enabling clinicians to identify and quickly react to dangerously low brain oxygen levels, as well as to monitor the oxygenation of other tissues, such as muscle and abdominal tissues in newborns. It also offers bedside vital signs monitors and accessories incorporating various combinations of measurement parameters for human and veterinary use, such as MAXNIBP and MAXIQ non-invasive blood pressure, pulse oximetry, electrocardiography (ECG), temperature, and capnography; and supplies and services, including neonatal intensive care vital signs supplies, such as electrodes and skin temperature probes, as well as various repair services. The company ma

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-0.29 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -0.62% Sales Growth - Q/Q-0.36% P/E-3.52
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-33.61% ROE-69.76% ROI-41.55%
Current Ratio4.74 Quick Ratio3.97 Long Term Debt/Equity0.48 Debt Ratio0.37
Gross Margin43.17% Operating Margin-27.68% Net Profit Margin-31.6% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities7.54 M Cash From Investing Activities-210 K Cash From Operating Activities-740 K Gross Profit2.67 M
Net Profit-1.52 M Operating Profit-1.3 M Total Assets21.63 M Total Current Assets18.05 M
Total Current Liabilities3.81 M Total Debt7.56 M Total Liabilities11.21 M Total Revenue5.81 M
Technical Data
High 52 week2.67 Low 52 week1.02 Last close1.66 Last change-4.05%
RSI28.95 Average true range0.08 Beta0.38 Volume57.95 K
Simple moving average 20 days-11.14% Simple moving average 50 days-7.88% Simple moving average 200 days-11.3%
Performance Data
Performance Week1.22% Performance Month-13.09% Performance Quart-6.74% Performance Half-24.89%
Performance Year39.5% Performance Year-to-date3.75% Volatility daily4.25% Volatility weekly9.51%
Volatility monthly19.49% Volatility yearly67.52% Relative Volume801.68% Average Volume40.01 K
New High New Low


2019-03-19 09:43:00 | Moore Kuehn, PLLC Announces Investigation of CAS Medical Systems, Inc. Acquisition

2019-03-14 14:07:00 | CAS MEDICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces an Investigation of CAS Medical Systems, Inc. CASM Over the Proposed Merger of the Company with Edwards Lifesciences Corporation

2019-03-05 13:10:00 | INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition

2019-03-04 21:34:51 | CASM, ELLI, and LABL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

2019-03-04 07:00:00 | Opsens Appoints Alan Milinazzo as Executive Chairman of the Board of Directors

2019-02-18 14:25:00 | Brodsky & Smith, LLC Announces an Investigation of CAS Medical Systems, Inc. - CASM

2019-02-15 15:51:00 | CAS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CAS Medical Systems, Inc. - CASM

2019-02-15 15:47:00 | SHAREHOLDER ALERT: WeissLaw LLP Investigates CAS Medical Systems, Inc.

2019-02-14 13:47:00 | Lifshitz & Miller LLP Announces Investigation of CAS Medical Systems, Inc., Entegra Financial Corp., Fidelity Southern Corporation, First Data Corporation, Kinderhook Bank Corp., Maxwell Technologies, Inc., Ohr Pharmaceutical, Inc., and Owens Realty Mortg

2019-02-12 19:09:20 | Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of CAS Medical Systems, Inc. CASM on Behalf of Stockholders and Encourages CASM Investors to Contact the Firm

2019-02-12 15:34:00 | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of CAS Medical Systems, Inc.

2019-02-12 14:25:00 | These Healthcare Stocks Could Surpass Investor Expectations

2019-02-12 12:01:00 | CAS MEDICAL SYSTEMS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

2019-02-12 10:50:59 | CAS Medical Surges As Edwards Lifesciences Agrees To Buy Medtech Company In $100M Deal

2019-02-12 09:44:53 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of CAS Medical Systems, Inc. to Edwards Lifesciences Corporation is Fair to Shareholders

2019-02-12 09:39:00 | CAS Medical Systems stock rockets to pace Nasdaq gainers after Edwards Lifesciences buyout deal

2019-02-12 08:30:00 | Edwards Lifesciences Enters Into Agreement To Acquire CASMED

2019-01-18 14:50:18 | Should You Worry About CAS Medical Systems, Inc.’s NASDAQ:CASM CEO Pay Cheque?

2019-01-04 13:40:00 | CASM: Q4 2019 Preannouncement, Initial 2019 Guidance, OEM Cable Launch Expected Mid-2019

2019-01-03 16:05:00 | CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year

2018-11-28 08:00:00 | CASMED to Present at the 11th Annual LD Micro Main Event Conference on December 5

2018-11-13 08:45:00 | New Research Coverage Highlights CAS Medical, Saia, Core Laboratories N.V, Perceptron, CRISPR Therapeutics AG, and IEC Electronics — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-11-12 14:39:38 | A Look At The Fair Value Of CAS Medical Systems Inc NASDAQ:CASM

2018-11-05 09:45:00 | CASM: Competitive Wins Resulting in Accelerating Consumable Revenue, Rapidly Improving Profitability

2018-10-31 18:09:59 | Edited Transcript of CASM earnings conference call or presentation 31-Oct-18 2:00pm GMT

2018-10-31 08:00:00 | CASMED Reports Third-Quarter 2018 Financial Results

2018-10-24 08:00:00 | CASMED to Report Third-Quarter 2018 Financial Results and Hold Conference Call on October 31

2018-08-31 14:44:00 | Penny Stocks to Watch for September 2018

2018-08-06 14:00:00 | CASM: FORE-SIGHT Momentum Continues, Moving PT to $4.50/share

2018-08-02 15:24:27 | Edited Transcript of CASM earnings conference call or presentation 2-Aug-18 2:00pm GMT

2018-08-02 08:00:00 | CAS Medical Systems, Inc. to Host Earnings Call

2018-08-02 08:00:00 | CASMED Reports Second Quarter 2018 Financial Results

2018-07-31 13:37:00 | Penny Stocks to Watch for August 2018

2018-07-27 11:12:43 | CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2

2018-06-07 07:15:00 | Wired News - Halyard Health to Buy CoolSystems; Marketed as Game ReadyR

2018-05-29 08:00:00 | CASMED to Present at the 8th Annual LD Micro Invitational Conference on June 5

2018-05-16 09:45:00 | CASM: Q1: FORE-SIGHT Revenue Jumps 20% in Q1. Sensors Sales Accelerating. Moving PT to $4.00/share

2018-05-16 08:00:00 | FDA Clears CASMED’s FORE-SIGHT Tissue Oximetry OEM Module

2018-05-10 19:46:35 | Edited Transcript of CASM earnings conference call or presentation 10-May-18 2:00pm GMT

2018-05-10 08:00:00 | CASMED Reports First-Quarter 2018 Financial Results

2018-05-03 08:00:00 | CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10

2018-03-27 09:30:00 | CASM: Q4 2017 Financial Results: Record Revenue, Lowest Op Loss. Momentum Expected to Continue

2018-03-14 22:45:28 | Edited Transcript of CASM earnings conference call or presentation 14-Mar-18 2:00pm GMT

2018-03-14 08:00:00 | CASMED Reports 2017 Fourth-Quarter and Full-Year Financial Results

2018-03-07 08:00:00 | CASMED to Report Fourth-Quarter and 2017 Full-Year Financial Results and Hold Conference Call on March 14

2018-02-27 16:23:20 | What does CAS Medical Systems Inc’s NASDAQ:CASM Balance Sheet Tell Us About Its Future?

2018-01-24 08:00:00 | CASMED Submits FORE-SIGHT® OEM Module 510k to FDA

2018-01-04 09:21:01 | CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter

2017-12-07 13:10:20 | ETFs with exposure to CAS Medical Systems, Inc. : December 7, 2017

2017-12-05 09:23:01 | CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017